120 related articles for article (PubMed ID: 15839202)
1. [Coordination inhibition of the proliferation of MCF-7 by enhancing expression of p53,p21 and decreasing expression of c-myc].
Zhang HJ; Wang N; Zhu XY; Sang JL; He DC
Shi Yan Sheng Wu Xue Bao; 2005 Feb; 38(1):16-22. PubMed ID: 15839202
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
3. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
Liu J; Li J; Sidell N
Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
[TBL] [Abstract][Full Text] [Related]
4. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
Zhou CH; Peng XD; Wu J; Zhang P; Zhao ZR; Wei DP; Zhang CJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):373-7. PubMed ID: 18575318
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
Girgert R; Hanf V; Emons G; Gründker C
Bioelectromagnetics; 2010 Apr; 31(3):237-45. PubMed ID: 19882681
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
Moh MC; Zhang T; Lee LH; Shen S
Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
[TBL] [Abstract][Full Text] [Related]
8. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
9. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny MV; Prabhu NS; El-Deiry WS
Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
[TBL] [Abstract][Full Text] [Related]
10. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J; Kim S; Yang JH; Nam SJ; Lee JE
Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.
Hwang-Verslues WW; Sladek FM
Mol Endocrinol; 2008 Jan; 22(1):78-90. PubMed ID: 17885207
[TBL] [Abstract][Full Text] [Related]
12. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.
Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Liu X; Yu H; Cai H; Wang Y
J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
[TBL] [Abstract][Full Text] [Related]
14. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
[TBL] [Abstract][Full Text] [Related]
15. Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.
Graves TG; Harr MW; Crawford EL; Willey JC
Mol Cancer; 2006 Jan; 5():1. PubMed ID: 16403226
[TBL] [Abstract][Full Text] [Related]
16. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
[TBL] [Abstract][Full Text] [Related]
17. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.
Ceballos E; Delgado MD; Gutierrez P; Richard C; Müller D; Eilers M; Ehinger M; Gullberg U; León J
Oncogene; 2000 Apr; 19(18):2194-204. PubMed ID: 10822369
[TBL] [Abstract][Full Text] [Related]
18. [Vitexicarpin affects proliferation and apoptosis in mutated p53 breast cancer cell].
Song YC; Zhang X; Lei GY; Dang CX
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):703-7. PubMed ID: 20450732
[TBL] [Abstract][Full Text] [Related]
19. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
Sharma K; Patel YC; Srikant CB
Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
[TBL] [Abstract][Full Text] [Related]
20. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
Jiang D; Wang X; Liu X; Li F
Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
